Chairperson, Danny Katz, General Manager, Bristol-Myers Squibb 

 

Committee Members:

• Mati Gil, Head of Government Affairs Corporate & International Markets, Teva Pharmaceuticals

• Dror Harats, CEO, Vascular Biogenics Ltd.

• Tali Rosin, Hear of Public Affairs & Policy Manager , Pfizer Pharmaceuticals Israel

• Yoel Lipschitz, VP Regulatory Affairs & Market Access, Medison Pharma

• Avi Buskila, CEO, SAREL Logistics Solutions & Producrs for Advanced Medicin Ltd.

• Orna Steinberger, CEO, Boehringer Ingelheim Israel Ltd.

• Tina Meerry Melusyan, CEO, Sanofi Ltd.

• Tammy Altarac, Managing Director, MSD Israel

• Dalit Hazan, VP Regulatory Affair, PolyPid Ltd.

• Avraham Raz, CEO, Eli Lilly Israel Ltd.

• Ron  Babecoff, CEO, BiondVax Pharmaceuticals Ltd.

• Yaron Itzhari, CEO, Medronic Trading

• Avi Danziger, CEO, Roche Pharmaceuticals (Israel) Ltd

       

      Zohar Yahalom, HFN, Legal Advisor            

      Idit Chernovitz, Committee Consultant